Patents by Inventor Geert Van Der Avoort

Geert Van Der Avoort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20230302024
    Abstract: This invention relates to solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
    Type: Application
    Filed: May 5, 2023
    Publication date: September 28, 2023
    Inventors: Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Eugeen Maria Jozef JANS, Roel Jos M. MERTENS, Geert VAN DER AVOORT
  • COMPOSITIONS COMPRISING ATICAPRANT
    Publication number: 20230277500
    Abstract: The present disclosure relates to compositions, including oral compositions in the form of tablets, comprising aticaprant and methods of using the same.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 7, 2023
    Inventors: Nicolaas Martha Felix Goyvaerts, Mark Schmidt, Vanina Popova, Adam Savitz, Rama Melkote, Wayne C. Drevets, Srihari Gopal, Darrel Pemberton, Chakradhar Lagishetty, Iva Kezic, Mahesh N. Samtani, Tom Huybrechts, Geert Van der Avoort, Matthieu Ravelingien, Laura Martinez Marcos, Tatiana Marcozzi, Katarina Jokicevic
  • Darunavir combination formulations
    Patent number: 11654150
    Abstract: This invention relate to solid oral dosage forms of tire HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulation thereof.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: May 23, 2023
    Assignee: Janssen Sciences Ireland UC
    Inventors: Urbain Alfons C. Delaet, Philip Erna H. Heyns, Eugeen Maria Jozef Jans, Roel Jos M. Mertens, Geert Van Der Avoort
  • FORMULATIONS OF AZAINDOLE COMPOUNDS
    Publication number: 20200397784
    Abstract: The present invention relates to pharmaceutical compositions, each comprising a multitude of granules that make up an intragranular phase of the composition, wherein the granules are produced by fluid bed granulation and comprise a HCl salt of Compound (1).xH2O wherein x is from 0 to 3, and one or more excipients selected from a disintegrant, a binder, and a wetting agent. The pharmaceutical composition also comprises one or more excipients that make up an extragranular phase of the composition, selected from a diluent, a disintegrant, a glidant, and a lubricant. The invention also relates to processes for producing the pharmaceutical compositions of the invention. The invention further relates to uses and methods of the pharmaceutical compositions in reducing the amount of influenza viruses in a biological in vitro sample or in a subject, inhibiting the replication of influenza viruses in a biological in vitro sample or in a subject, and treating influenza in a subject.
    Type: Application
    Filed: April 17, 2020
    Publication date: December 24, 2020
    Inventors: Gopal Rajan Ranga Rajan, Geert Van Der Avoort, Rudolf Josephus Dijmphna Leemans
  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20200093840
    Abstract: This invention relate to solid oral dosage forms of tire HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulation thereof.
    Type: Application
    Filed: November 27, 2019
    Publication date: March 26, 2020
    Inventors: Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Eugeen Maria Jozef JANS, Roel Jos M. MERTENS, Geert VAN DER AVOORT
  • DARUNAVIR COMBINATION FORMULATIONS
    Publication number: 20140142070
    Abstract: This invention relates to solid oral dosage forms of the HIV inhibitor Darunavir and/or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
    Type: Application
    Filed: July 6, 2012
    Publication date: May 22, 2014
    Applicant: Janssen R&D Ireland
    Inventors: Urbain Alfons C Delaet, Philip Erna H. Heyns, Eugeen Maria Jozef Jans, Roel Jos M. Mertens, Geert Van Der Avoort